ghk cu tb 500 bpc 157 KLOW - GHK-Cu - BPC-157 - TB-500 BAC Water | Research Size:1000mg bpc-157

ghk cu tb 500 bpc 157 KLOW - GHK-Cu - BPC-157 - TB-500 BAC Water | Research Size:1000mg bpc-157

BAC Water | Research Peptide EU | PEAK_PEPTIDE

Therapeutic Research Protocol Dose: 10 – 20 mg Duration: 20 – 30 days Frequency: Daily, split into morning and evening administration Cycle Interval: 3 – 4 months off before repeating Goal / Description: Targeted regimen for advanced cartilage degeneration and osteoarthritis models

bpc-157

Size:1000mg

Joint function and pain relief: By modulating the neurogenic inflammatory cascade and reducing the degenerative erosion in the joint capsule area, BPC-157 might contribute to the relief of joint pain